Traumatic Brain InjuriesTraVi_IINCT06776107
Mortality in Brain Injury at the Intensive Care Unit (TraVi II)
An observational study of Traumatic Brain Injuries, run by Hospital Departamental de Villavicencio at 1 site in Colombia.
Trial summary
Introduction: traumatic brain injuries are a leading cause of disability and mortality in the young population, associated mainly with traffic road accidents and violent wounds. The study aimed to analyze factors related to the mortality in patients with brain injury admitted to the intensive care unit. Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Traumatic Brain Injuries
- What is being tested?
- Risk factor present
- How many people
- 80 participants
- Where
- 1 siteColombia
- Study dates
- 1 Jan 2019to 30 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population was patients with traumatic brain injury who were admitted to the intensive care unit.
Who may be able to join
- Traumatic brain injury.
- Admitted to the intensive care unit.
Who cannot join
- Remission from another hospital.
- Decease for causes other than the brain injury.
Trial locations and contacts
1 site in 1 country.
Colombia1 site
Hospital Departamental de Villavicencio
Villavicencio, Meta Department, 50001
About this study
Official title: Factors Associated With Mortality in Brain Injury at the Intensive Care Unit. A Cross-sectional Trial, 2019-2023 (TraVi II)
Introduction: traumatic brain injuries are a leading cause of disability and mortality in the young population, associated mainly with traffic road accidents and violent wounds. The study aimed to analyze factors related to the mortality in patients with brain injury admitted to the intensive care unit.
Methodology: Between 2019 and 2024, an analytical cross-sectional trial at Hospital Departamental de Villavicencio, Colombia was performed. Information was selected from the intensive care unit (ICU) database. Variables of interest and outcomes, such as mortality and ICU length of stay, were identified. The comparison was performed with the software Prism® for Mac iOS and Wizard® for the predictive model.
Results: The study will show the factors associated with mortality of brain injury patients admitted to the intensive care unit.
Read the detailed description
Objective: The study aimed to analyze factors related to the mortality in patients with brain injury admitted to the intensive care unit.
Methodology: Between 2019 and 2024, an analytical cross-sectional trial at Hospital Departamental de Villavicencio, Colombia, a reference center for the Colombian Orinoco region with 400 hospital beds and 53 polyvalent ICU beds was performed. Information was selected from 2,154 admission registers in the intensive care unit (ICU) database. Data of admissions considered for review were from patients with diagnostic codes of brain injury, brain edema, polytrauma, ventilatory failure, neurogenic shock, and traumatic subarachnoid hemorrhage. All the registries with codes S00-S09 from the 10th revision of the International Diseases Classification from the World Health Organization were reviewed. Variables of interest and outcomes, such as mortality and ICU length of stay, were identified. The comparison was performed with the software Prism® for Mac iOS and Wizard® for the predictive model.
Results: The study will show the factors associated with mortality of brain injury patients admitted to the intensive care unit.
- Conditions
- Traumatic Brain Injuries
- Being tested
- Risk factor present
- Keywords
- Brain Injuries, Traumatic Brain Injuries, Brain Concussion, Traffic Accidents, Critical Care, Colombia
- Medical subject headings
- Brain Injuries, Traumatic, Brain Injuries, Brain Concussion
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Risk factor presentOther
Demographic, and severity.
| Study group | Role | What they receive |
|---|---|---|
| Mortality | Survival Receives: Other: Risk factor present |
What is being measured
The primary outcome is the main question the study is designed to answer.
ICU mortality
Mortality at the ICU
Measured: 30 days
Secondary outcomes (1)
ICU length of stay
Length of stay at the intensive care unit.
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2025
- Study start1 Jan 2019
- Primary completion30 Nov 2024
- Study completion30 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Traumatic Brain InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Departamental de Villavicencio
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Norton Perez-Gutierrez, MD, Hospital Departamental de Villavicencio
- Investigators
- Norton Perez, MD, Principal investigator, Hospital Departamental de Villavicencio
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06776107
- Sponsor's protocol ID
- GRIVI_2024_01_TCE
- Acronym
- TraVi_II
- Status last verified
- Jan 2025
- First submitted
- 9 Dec 2024
- Last updated
- 15 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: It contains sensible information about patients.
Publications
Ortega Zufiria JM, Prieto NL, Cuba BC, Degenhardt MT, Nunez PP, Lopez Serrano MR, Lopez Raigada AB. [Mild head injury]. Surg Neurol Int. 2018 Jan 22;9(Suppl 1):S16-S28. doi: 10.4103/sni.sni_371_17. eCollection 2018. Spanish.
PubMed 29430327Gonzalez-Robledo J, Martin-Gonzalez F, Moreno-Garcia M, Sanchez-Barba M, Sanchez-Hernandez F. Prognostic factors associated with mortality in patients with severe trauma: from prehospital care to the Intensive Care Unit. Med Intensiva. 2015 Oct;39(7):412-21. doi: 10.1016/j.medin.2014.06.004. Epub 2014 Sep 2. English, Spanish.
PubMed 25189470Fonseca J, Liu X, Oliveira HP, Pereira T. Mortality prediction using medical time series on TBI patients. Comput Methods Programs Biomed. 2023 Dec;242:107806. doi: 10.1016/j.cmpb.2023.107806. Epub 2023 Sep 21.
PubMed 37832428Buh FC, Sumbele IUN, Maas AIR, Motah M, Pattisapu JV, Youm E, Meh BK, Kobeissy FH, Wang KW, Hutchinson PJA, Taiwe GS. Traumatic Brain Injury in Cameroon: A Prospective Observational Study in a Level I Trauma Centre. Medicina (Kaunas). 2023 Aug 28;59(9):1558. doi: 10.3390/medicina59091558.
PubMed 37763678Domensino AF, Tas J, Donners B, Kooyman J, van der Horst ICC, Haeren R, Aries MJH, van Heugten C. Long-Term Follow-Up of Critically Ill Patients With Traumatic Brain Injury: From Intensive Care Parameters to Patient and Caregiver-Reported Outcome. J Neurotrauma. 2024 Jan;41(1-2):123-134. doi: 10.1089/neu.2022.0474. Epub 2023 Oct 10.
PubMed 37265152Launey Y, Coquet A, Lasocki S, Dahyot-Fizelier C, Huet O, Le Pabic E, Roquilly A, Seguin P. Factors associated with an unfavourable outcome in elderly intensive care traumatic brain injury patients. a retrospective multicentre study. BMC Geriatr. 2022 Dec 30;22(1):1004. doi: 10.1186/s12877-022-03651-x.
PubMed 36585608Rowe M, Brown J, Marsh A, Thompson J. Predicting Mortality Following Traumatic Brain Injury or Subarachnoid Hemorrhage: An Analysis of the Validity of Standardized Mortality Ratios Obtained From the APACHE II and ICNARC H-2018 Models. J Neurosurg Anesthesiol. 2023 Jul 1;35(3):292-298. doi: 10.1097/ANA.0000000000000831. Epub 2022 Feb 4.
PubMed 35125410Luostarinen T, Vehvilainen J, Lindfors M, Reinikainen M, Bendel S, Laitio R, Hoppu S, Ala-Kokko T, Skrifvars M, Raj R. Trends in mortality after intensive care of patients with traumatic brain injury in Finland from 2003 to 2019: a Finnish Intensive Care Consortium study. Acta Neurochir (Wien). 2022 Jan;164(1):87-96. doi: 10.1007/s00701-021-05034-4. Epub 2021 Nov 2.
PubMed 34725728Rubiano AM, Griswold DP, Jibaja M, Rabinstein AA, Godoy DA. Management of severe traumatic brain injury in regions with limited resources. Brain Inj. 2021 Sep 19;35(11):1317-1325. doi: 10.1080/02699052.2021.1972149. Epub 2021 Sep 7.
PubMed 34493135Kokkinou M, Kyprianou TC, Kyriakides E, Constantinidou F. A population study on the epidemiology and outcome of brain injuries in intensive care. NeuroRehabilitation. 2020;47(2):143-152. doi: 10.3233/NRE-203111.
PubMed 32741786Venkatasubba Rao CP, Suarez JI, Martin RH, Bauza C, Georgiadis A, Calvillo E, Hemphill JC 3rd, Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators. Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2. Neurocrit Care. 2020 Feb;32(1):88-103. doi: 10.1007/s12028-019-00835-z.
PubMed 31486027Pappacena S, Bailey M, Cabrini L, Landoni G, Udy A, Pilcher DV, Young P, Bellomo R. Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage. Minerva Anestesiol. 2019 Aug;85(8):830-839. doi: 10.23736/S0375-9393.19.13307-X. Epub 2019 Feb 7.
PubMed 30735020Volovici V, Ercole A, Citerio G, Stocchetti N, Haitsma IK, Huijben JA, Dirven CMF, van der Jagt M, Steyerberg EW, Nelson D, Cnossen MC, Maas AIR, Polinder S, Menon DK, Lingsma HF. Intensive care admission criteria for traumatic brain injury patients across Europe. J Crit Care. 2019 Feb;49:158-161. doi: 10.1016/j.jcrc.2018.11.002. Epub 2018 Nov 8.
PubMed 30447560Raj R, Bendel S, Reinikainen M, Hoppu S, Luoto T, Ala-Kokko T, Tetri S, Laitio R, Koivisto T, Rinne J, Kivisaari R, Siironen J, Skrifvars MB. Traumatic brain injury patient volume and mortality in neurosurgical intensive care units: a Finnish nationwide study. Scand J Trauma Resusc Emerg Med. 2016 Nov 8;24(1):133. doi: 10.1186/s13049-016-0320-6.
PubMed 27821129
Study at a glance
From the registry record, last updated by the sponsor on 15 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Factors Associated With Mortality in Brain Injury at the Intensive Care Unit. A Cross-sectional Trial, 2019-2023 (TraVi II)
- ClinicalTrials.gov ID
- NCT06776107
- Acronym / sponsor ID
- TraVi_II / GRIVI_2024_01_TCE
- Conditions
- Traumatic Brain Injuries
- Keywords
- Brain Injuries, Traumatic Brain Injuries, Brain Concussion, Traffic Accidents, Critical Care, Colombia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Hospital Departamental de VillavicencioUniversity, hospital or other
- Study start
- 1 Jan 2019 (actual)
- Primary completion
- 30 Nov 2024 (actual)
- Study completion
- 30 Nov 2024 (actual)
- First posted
- 15 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction: traumatic brain injuries are a leading cause of disability and mortality in the young population, associated mainly with traffic road accidents and violent wounds. The study aimed to analyze factors related to the mortality in patients with brain injury admitted to the intensive care unit.
Methodology: Between 2019 and 2024, an analytical cross-sectional trial at Hospital Departamental de Villavicencio, Colombia was performed. Information was selected from the intensive care unit (ICU) database. Variables of interest and outcomes, such as mortality and ICU length of stay, were identified. The comparison was performed with the software Prism® for Mac iOS and Wizard® for the predictive model.
Results: The study will show the factors associated with mortality of brain injury patients admitted to the intensive care unit.
Detailed description
Objective: The study aimed to analyze factors related to the mortality in patients with brain injury admitted to the intensive care unit.
Methodology: Between 2019 and 2024, an analytical cross-sectional trial at Hospital Departamental de Villavicencio, Colombia, a reference center for the Colombian Orinoco region with 400 hospital beds and 53 polyvalent ICU beds was performed. Information was selected from 2,154 admission registers in the intensive care unit (ICU) database. Data of admissions considered for review were from patients with diagnostic codes of brain injury, brain edema, polytrauma, ventilatory failure, neurogenic shock, and traumatic subarachnoid hemorrhage. All the registries with codes S00-S09 from the 10th revision of the International Diseases Classification from the World Health Organization were reviewed. Variables of interest and outcomes, such as mortality and ICU length of stay, were identified. The comparison was performed with the software Prism® for Mac iOS and Wizard® for the predictive model.
Results: The study will show the factors associated with mortality of brain injury patients admitted to the intensive care unit.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Mortality | – | Other: Risk factor presentSurvival |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population was patients with traumatic brain injury who were admitted to the intensive care unit.
Key inclusion criteria (2 listed)
- Traumatic brain injury.
- Admitted to the intensive care unit.
Key exclusion criteria (2 listed)
- Remission from another hospital.
- Decease for causes other than the brain injury.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Risk factor presentDemographic, and severity. | Other | Mortality |
Primary outcome
ICU mortality
Time frame: 30 days
Mortality at the ICU
1 secondary outcome
ICU length of stay
Time frame: 30 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jan 2025.
- Results publication: PubMed 29430327Ortega Zufiria JM, Prieto NL, Cuba BC, Degenhardt MT, Nunez PP, Lopez Serrano MR, Lopez Raigada AB. [Mild head injury]. Surg Neurol Int. 2018 Jan 22;9(Suppl 1):S16-S28. doi: 10.4103/sni.sni_371_17. eCollection 2018. Spanish.
- Results publication: PubMed 25189470Gonzalez-Robledo J, Martin-Gonzalez F, Moreno-Garcia M, Sanchez-Barba M, Sanchez-Hernandez F. Prognostic factors associated with mortality in patients with severe trauma: from prehospital care to the Intensive Care Unit. Med Intensiva. 2015 Oct;39(7):412-21. doi: 10.1016/j.medin.2014.06.004. Epub 2014 Sep 2. English, Spanish.
- Results publication: PubMed 37832428Fonseca J, Liu X, Oliveira HP, Pereira T. Mortality prediction using medical time series on TBI patients. Comput Methods Programs Biomed. 2023 Dec;242:107806. doi: 10.1016/j.cmpb.2023.107806. Epub 2023 Sep 21.
- Results publication: PubMed 37763678Buh FC, Sumbele IUN, Maas AIR, Motah M, Pattisapu JV, Youm E, Meh BK, Kobeissy FH, Wang KW, Hutchinson PJA, Taiwe GS. Traumatic Brain Injury in Cameroon: A Prospective Observational Study in a Level I Trauma Centre. Medicina (Kaunas). 2023 Aug 28;59(9):1558. doi: 10.3390/medicina59091558.
- Results publication: PubMed 37265152Domensino AF, Tas J, Donners B, Kooyman J, van der Horst ICC, Haeren R, Aries MJH, van Heugten C. Long-Term Follow-Up of Critically Ill Patients With Traumatic Brain Injury: From Intensive Care Parameters to Patient and Caregiver-Reported Outcome. J Neurotrauma. 2024 Jan;41(1-2):123-134. doi: 10.1089/neu.2022.0474. Epub 2023 Oct 10.
- Results publication: PubMed 36585608Launey Y, Coquet A, Lasocki S, Dahyot-Fizelier C, Huet O, Le Pabic E, Roquilly A, Seguin P. Factors associated with an unfavourable outcome in elderly intensive care traumatic brain injury patients. a retrospective multicentre study. BMC Geriatr. 2022 Dec 30;22(1):1004. doi: 10.1186/s12877-022-03651-x.
- Results publication: PubMed 35125410Rowe M, Brown J, Marsh A, Thompson J. Predicting Mortality Following Traumatic Brain Injury or Subarachnoid Hemorrhage: An Analysis of the Validity of Standardized Mortality Ratios Obtained From the APACHE II and ICNARC H-2018 Models. J Neurosurg Anesthesiol. 2023 Jul 1;35(3):292-298. doi: 10.1097/ANA.0000000000000831. Epub 2022 Feb 4.
- Results publication: PubMed 34725728Luostarinen T, Vehvilainen J, Lindfors M, Reinikainen M, Bendel S, Laitio R, Hoppu S, Ala-Kokko T, Skrifvars M, Raj R. Trends in mortality after intensive care of patients with traumatic brain injury in Finland from 2003 to 2019: a Finnish Intensive Care Consortium study. Acta Neurochir (Wien). 2022 Jan;164(1):87-96. doi: 10.1007/s00701-021-05034-4. Epub 2021 Nov 2.
- Results publication: PubMed 34493135Rubiano AM, Griswold DP, Jibaja M, Rabinstein AA, Godoy DA. Management of severe traumatic brain injury in regions with limited resources. Brain Inj. 2021 Sep 19;35(11):1317-1325. doi: 10.1080/02699052.2021.1972149. Epub 2021 Sep 7.
- Results publication: PubMed 32741786Kokkinou M, Kyprianou TC, Kyriakides E, Constantinidou F. A population study on the epidemiology and outcome of brain injuries in intensive care. NeuroRehabilitation. 2020;47(2):143-152. doi: 10.3233/NRE-203111.
- Results publication: PubMed 31486027Venkatasubba Rao CP, Suarez JI, Martin RH, Bauza C, Georgiadis A, Calvillo E, Hemphill JC 3rd, Sung G, Oddo M, Taccone FS, LeRoux PD; PRINCE Study Investigators. Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2. Neurocrit Care. 2020 Feb;32(1):88-103. doi: 10.1007/s12028-019-00835-z.
- Results publication: PubMed 30735020Pappacena S, Bailey M, Cabrini L, Landoni G, Udy A, Pilcher DV, Young P, Bellomo R. Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage. Minerva Anestesiol. 2019 Aug;85(8):830-839. doi: 10.23736/S0375-9393.19.13307-X. Epub 2019 Feb 7.
- Individual participant dataSharing planned: No. It contains sensible information about patients.
Related trials for Traumatic Brain Injuries
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
Not yet recruitingPhase 1
Nanopulse Laser Therapy
TBI (Traumatic Brain Injury)
RecruitingObservational study
Effect of Different Intravenous Fluids on Post-operative Chronic Subdural Hematoma Size and Recurrence
Chronic Subdural Hematoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Norton Perez, MD principal investigator
Hospital Departamental de Villavicencio
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Traumatic Brain Injuries, run by Hospital Departamental de Villavicencio at 1 site in Colombia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ICU mortality (time frame: 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06776107, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2025.